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Nomenclature, methods, definitions 
Ovarian germ cell tumours 
Testicular germ cell tumours 
Sacrococcygeal germ cell tumours 
Retroperitoneal germ cell tumours 
Renal germ cell tumours 
Mediastinal germ cell tumours 
Paravertebral germ cell tumours 
Germ cell tumours of the head and neck 
Summary: Immature teratomas 













GERM CELL TUMOURS OF CHILDHOOD 
The aim of the current study is the characterisation (primarily pathological, but with clinical co
rrelation) of the germ 
cell tumours seen in the Pathology Department of the Red Cross Childrens Hospital since its in
ception in 1956 
(through to the year 1995, date of commencement of the study). 
Study population -
Infants and children from birth to 13 years of age (of all population groups. but predominantly 
those from the 
disadvantaged black and mixed race communities of the Greater Cape Town metropolitan area)
. 
NOMENCLATURE. 
A modification of the W.H.O. classification of ovarian [79] and testicular tumours [50] is emp
loyed. 
I) Malignant germ cell tumours. 









Any of the above tumours mixed with each other, or with a mature/immature teratomatous 
component. 
II) Immature teratomas - Grades I - III. 
III) Mature teratornas. 
(Although the neoplasms iil this study are subsumed under the all embracing term "germ cell". 
it is acknowledged 
that the histogenesis of thesr. fascinating tumours is still open to debate. Besides germ cell, other hyp
otheses of origin 
have included: 
- nongerrninal cells of the early conceptus. or "embryonic" cells. 
- totipotential "stem cells". 
- "included" or conjoined and maldeveloped twins. 
- different cell types, and possibly by different pathogenesis, depending on the anatomic site o
f the 
neoplasm). 
METHODS AND DEFINITIONS. 
TUMOUR SPECIFIC HISTOLOGICAL FEATURES EVALUATED. 
The study was performed retrospectively by review of archival material. Haematoxylin and eos
in stained slides were 
available for all cases, plus PAS diastase stains for the vast majority of yolk sac tumours. Immu
noperoxidase stains 
where relevant, were available for the more recent cases. The number of sections taken per spe
cimen varied 
considerably. For the more recent, the protocol of one block per cm. of maximum tumour diam
eter was invariably 
followed, whereas for the earlier cases, generally fewer sections were taken. 
(2) 
I) Malignant Germ Cell Tumours. 
A) Yolk sac tumours 
Enumeration of the histological patterns present, and which, if any, predominates £2. 5. 7. 7lll 
Classical patterns as described by Teilum £!091 and elaborated by Kurman & Norris £71. 
(i) Reticular/microcystic - Characteristic appearance - Network of variably sized cystic spaces lined 
by attenuated epithelial cells. Extra- or intracellular PAS positive (diastase resistant) hyaline 
globules invariably present. 
Grades I -ill. 
1 this study are subsumed un( 
~ fascinating tumours is sti: 1 
Reticular Y.S.T. pattern with several hyaline globules in field. 
(3) 
(ii) Pseudopapillary/endoderrnal sinus/festoon - Characteristic appearance - Papillary structures 
(Schiller-Duval bodies) present, consisting of a loose connective tissue core, penetrated by a central 
longitudinal capillary, and covered by a monolayer of primitive cuboidal or low columnar 
mitotically active epithelial cells. The papillary structures, themselves, projecting into a complex 
labyrinth of inter-anastamosing channels lined by epithelial cells. Hyaline globules are invariably 
identifiable. 
Classical festoon pattern - 5X magnification. 
Classical festoon pattern - lOX magnification. 
(4) 
(iii) Polyvesicular-vitelline - Characteristic appearance - Pear shaped "vesicles" lined
 at their 
narrow ends by cuboidal epithelium (often with infra- or supranuclear vacuoles) and at
 their broader 
ends by flattened mesothelial like cells. (The broad and narrow segments being though
t to represent 
the primary and secondary yolk sac vesicles respectively). A slight luminal constrictio
n is usually 
present at the interface between the 2 epithelial cell types. A dense spindle cell stroma
 may 
encompass the vesicles. Hyaline globules are usually identifiable. 
Polyvesicular vitelline pattern. 
(5) 
(iv) Solid - Characteristic appearance - Solid masses or rounded aggregates of small primitive 
epithelial cells with slightly vacuolated cytoplasm, large vesicular or hyperchromatic nuclei with 
prominent nucleoli, and accompanying brisk mitotic activity. As with the other histological 
patterns, hyaline globules are invariably present. This histological subtype needs to be distinguish
ed 
from: 
- Embryonal carcinoma - Features of value: 
- Isolated clusters of syncytiotrophobast invariably present in embryonal carcinoma, but 
extremely rarely seen in Y.S.T. 
- Presence of other Y.S.T. patterns especially - reticular, festoon or polyvesicular. 
- Embryonal carcinoma shows more profound cellular and nuclear pleomorphism, larger 
cells, and more prominent nucleoli. 
(Profuse numbers of intra- and extracellular hyaline globules plus diffusely positive 
immunoperoxidase staining for AFP may occur in embryonal carcinoma, as well as 
Y.S.T. CMJ ). 
- Y.S.T. with hepatoid differentiation (see description below). 
Additional subtypes (as described by Talerman (5) and others) 
(i) Papillary pattern - Characteristic appearance - Composed of papillary structures consisting o
f 
connective tissue cores lined by epithelial like cells showing prominent pleomorphism and mitotic
 
activity. (Differing from the pseudopapillary/festoon type by the lack of a penetrating central 
longitudinal vessel, plus the lack of projection of the core into an epithelial lined sinusoidal space)
. 
(ii) Macrocystic pattern - Characterised by the presence oflarge cystic spaces (in contrast to the 
microcysts of the classical reticular pattern). 
(iii) Alveolar-glandular pattern - Composed of gland-like spaces and cavities lined by flattened o
r 
cuboidal epithelial cells and surrounded by myxoid stroma. 
Alveolar-glandular pattern ofY.S.T. 
(6) 
More recently described histological sub-types [61. 62. 63, Ml 
(In early embryonic development the human yolk sac, and the primitive gut, 
are directly contiguous. 
These 2 structures being frequently referred to as the primary and secondary 
yolk sac vesicles 
respectively. This relationship with primordial gut structures is supported by
 the ultrastructural 
demonstration in yolk sac tumours, of cells resembling surface gut epithelium
, Paneth cells, gastric 
cells, and hepatocytes). 
(i) Y.S.T. with hepatoid differentiation - Solid growth pattern characterised 
by sheets and nests of 
mitotically active polygonal cells, with distinct cell borders, eosinophilic cyto
plasm, and a large 
central nucleus containing a single prominent nucleolus. (The neoplasm bea
ring considerable 
resemblance to a hepatocellular carcinoma). As with other yolk sac tumour g
rowth patterns hyaline 
globules are invariably identifiable. (Differentiation from a Y.S.T. with a sol
id growth pattern, plus 








Photograph demonstrating the grey area between YST with a solid pattern, a
nd that with hepatoid 
differentiation. 
(7) 
(ii) Y.S.T. with intestinal differentiation - Characteristic appearance - Nests or collections of 
primitive endodennal glands, showing varying degrees of differentiation - from primitive to well 
differentiated (resembling a mucin secreting adenocarcinoma). 
Reticular pattern with foci of glandular spaces - consistent with intestinal differentiation. 
(iii) Y.S.T. with endometrioid differentiation - Characteristic appearance - Prominent tubular -
glandular structure, epithelial cells hyperchromatic and columnar - shows a striking resemblance to 
endometrioid adenocarcinoma. 
(iv) The parietal yolk sac variant £31 - Characterised by the extracellular accumulation ofhyaline 
eosinophilic basement membrane like material, between adjacent tumour cells. This PAS positive 
hyaline material occurring most often in the form of bands, and less commonly as globular shapes. 
(8) 
B) Embryonal carcinoma - £5. MJ. 
Identifying features -
Masses of large primitive pleomorphic cells, demonstrating prominent mitotic activity and not infrequently abnormal 
mitoses, arranged in solid sheets or less commonly in the form of papillary processes and glandlike clefts. Areas of 
necrosis and haemorrhage are frequently evident. Clusters of syncytiotrophoblastic cells are invariably present. 
Differentiation from the solid pattern of yolk sac tumour is necessary, but may be difficult (see features of value 
above). 
Left half of field reticular Y.S.T. 
Right half - embryonal carcinoma with marked pleomorphism and numerous syncytiotrophoblastic giant cells. 
C) Choriocarcinoma -
Identifying features -
Presence of both cyto- and syncytiotrophoblast, plus frequent areas of necrosis, haemorrhage and vascular invasion. 
(9) 
D) Genninoma - £2. 51 
(When this neoplasm arises in the testis the apellation seminoma is used, in the ovary - dysgenninoma, and in 
extragonadal sites - germinoma). 
Characteristic appearance - Monotonous appearing cells, containing a central vesicular nucleus with two or three 
nucleoli, surrounded by a prominent rim of clear to granular cytoplasm, and arranged usually in agregates separated 
by fibrous septae containing a variable lymphoid infiltrate (with or without an accompanying granulomatous 
reaction). The component monotonous cells may at times be arranged in solid sheets or linear profiles, rather than 
aggregates, and necrosis is occasionally evident. 
Variants - Germinoma with syncytiotrophoblastic giant cells OIOJ. (The syncytiotrophoblastic 
giant cells may be distributed in clusters or more diffusely). 
Anaplastic variant - Defined by the presence of increased mitotic activity (three or more 
mitoses per high power field), nuclear pleomorphism and cellular anaplasia £ll0 . 
Classical germinoma with accompanying granulomatous inflammation. 
(10) 
II) Immature Teratomas. 
By definition these teratomas contain immature (embryonal) structures, as well as mature tissue, and no 
malignant germ cell elements. These tumours were graded after the system devised by Thurlbeck & Scully 
( 1960) to indicate the quantity of immature tissue present. 
Grade I - Immature tissue limited to a rare low power (x40) field, with no more than one such focus in any 
slide. 
Grade II - Immature tissue comprising more than one but less than four low power (x40) fields, within any 
individual slide. 
Grade ill - Immature tissue occupying four or more low power (x40) fields within any individual slide. 
Numerous neuroepithelial rosettes. 
ill) Mature Teratomas. 
By definition containing no immature or malignant elements. 
(11) 
TUMOUR NON SPECIFIC IDSTOLOGICAL FEATURES EVALUATED. 
The following histological features were evaluated to assess their prognostic importance: 
1. Mitotic rate per 10 high power fields (400 x magnification) - the average count from 30 randomly selected fields 
being utilized. 
2. Presence or absence of microscopic tumour necrosis (where the necrosis occupied more than 3 low power fields, 
x40 magnification, on any individual slide, it was considered to be extensive). 
Upper portion of photograph - Viable Y.S.T., reticular pattern, plus Schiller-Duval body in centre of field. 
Lower portion - tumour necrosis. 
(12) 
3. Vascular invasion - The criteria applied to distinguish definite vascular invasion from artefact, included one or 
more of the following: 
- penetration of the vessel wall by tumour 
- adhesion of luminal tumour to the endothelial surface 
- incorporation of luminal tumour within a thrombus 
'· 
Embryonal carcinoma with vascular space invasion. 
(13) 
4. Anaplasia - Defined by the presence of marked nuclear and cellular pleomorphism, with at least one nucleus 
being three times the size of those adjacent to it, with an accompanying ve:ry brisk mitotic rate. 
Left half of photograph - reticular Y.S.T. 
Right half - embcyonal carcinoma with syncytiotrophoblastic giant cell, plus single nucleus at least 3 times the size 
of the adjacent nuclei - meeting the defined criteria for anaplasia. 
(14) 
Additional histologic features evaluated: 
- Presence/absence of intratubular germ cell neoplasia in all malignant testicular neoplasms 
(immunoperoxiclase staining for placental alkaline phosphatase was, however, unfortunately not 
employed). 
- Presence/absence of hyaline globules in tumours with a yolk sac component. 
Intra plus extra cellular hyaline globules - high power veiw. 
- Presence/absence of granulomatous inflammation in the germinomatous malignancies. 
(15) 
MACROSCOPIC TUMOUR PATHOLOGY 
Information (size, consistency, and description of cut surface) obtained from archival histopathology reports. 
CLINICAL PARAMETERS 
The clinical data was obtained retrospectively from: 
- the folders of the oncology department 
- the general hospital medical folders 
- data presented at clinico-pathological meetings (involving the patient) 
- and biopsy specimen request forms. 
Clinical data recorded: 
- Year of presentation 
- Age 
- Sex 
- Clinical presentation 
- Extent of disease 
- Therapy administered 
- Response to therapy/clinical course 
- Duration of follow up. ''"ith clinical status at last examination. 
Extent of disease - In general (except in the case of malignant testicular g.c.t.), the extent of the disease has been 
given in descriptive terms, and numerical staging avoided. 
Testicular tumour staging. 
Stage I - Tumour confined to the testis. 
Stage II - Infradiaphragmatic lymph node involvement. 
Stage III - Supradiaphragmatic lymph node involvement or visceral metastases. 
(16) 
BREAKDOWN OF G.C.T. EVALUATED IN STUDY. 
A) Malignant 
I) With a YST component 
(But excluding those "ith a definite or possible 
embryonal carcinoma component). 
II) Y. S.T. with possible embryonal carcinoma component. 
III) G.C.T. with a definite embryonal carcinoma component. 
IV) Germinoma. 
V) Choriocarcinoma. 
Total number of malignant G.C.T. 
B) Immature Teratoma 
C) Mature Teratoma 








17 6 ( -occurring in 17 4 patients) 
(17) 
GONADAL GERM CELL TUMOURS. 
BREAKDOWN OF OVARIAN G.C.T. EVALUATED IN THE CURRENT STIJDY. 
A) Malignant 
I) With a Y. S.T. component (but excluding 
those with a definite or possible embryonal 
carcinoma component). 
II) With a Y.S.T. component and a possible 
embryonal carcinoma component. 
Ill) With a definite embryonal carcinoma component. 
IV) Choriocarcinoma. 
V) Dysgerminoma 
Total number of malignant ovarian g.c.t. 
B) Immature teratomas 
C) Mature teratomas 
Total number of childhood ovarian g.c.t. included in study 









FOOTNOTE TOT ABLE ON MALIGNANT OVARIAN G.C.T. (EXCLUDING DYSGERMINOMAS). 
rn Solid area noted with multiple syncytiotrophoblastic giant cells. 
Differential diagnosis lies between a solid pattern of yolk sac tumour, and a focus of embryonal carcinoma. 
FOOTNOTE TOT ABLE ON OVARIAN DYSGERMINOMAS. 
rn Superficial resemblance to reticular yolk sac tumour noted in many areas (as a consequence of prominent stromal 
oedema). 
U] Presented originally with an enlarged supraclavicular lymph node, the histology of which showed a metastatic 
dysgerminoma. Ovarian biopsies at this stage showed no evidence of tumour. 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































MATURE OVARIAN TERATOMAS 
Age Year Clinical Size (max diam in mm) & Other Follow up 
presentation macroscooic a_ ce 
3 yrs 1964 ? 90mm 
8yrs 1967 Abdominal pain 125mm Spina bifida at LS 
2 days duration Right ovary 
Multi cystic 
3 yrs 1962 Abdominal 601mn 
swelling Multicvstic 
? 1963 ? 35mm 
-9 yrs 1965 Acute torsion 40mm 
Multi cystic 
2 yrs 1965 ? 100mm 
Multicvstic 
12 yrs 1966 Abdominal mass Left ovary 4 yrs later - well 
120mm 
3 yrs 1970 Abdominal mass Right ovary 
Cystic 
70mm 
8 yrs 1970 Abdominal mass Left ovary 
Cystic 
100mm 
6 1967 Abdominal mass Left ovary Death from 
months Multiloculated postoperative 
120mm complications 
3 weeks 1973 Acute torsion Left ovary 
Cystic 
50mm 
6yrs 1974 Abdominal mass Right ovary 
Cystic 
90mm 
6yrs 1974 Abdominal mass Cystic 
60mm 
21 1981 Acute torsion 120mm 
months Cystic 
7yrs 1979 Acute torsion Right ovary 
Cystic 
80mm 
6yrs 1984 Recurrent urinary Left ovary 
tract infections Cystic 
30mm 
5yrs 1991 Abdominal mass 120mm 
Cystic 
3 yrs 1991 Abdominal mass Right ovary 
120mm 
Cystic 
8 yrs 1975 Abdominal pain & Right ovary 
mass - torsion 60mm 
Cystic 
lOyrs 1972 Abdominal Bilateral teratomas 
swelling & acute 120mm + 22mm respectively 
torsion Both cystic 
3 yrs 1979 ? Cystic 
70mm 
MATURE OVARIAN TERATOMAS 
Age Year Clinical Size (max diam in mm) & Other Follow up 
presentation macroscopic appearance 
6yrs& 1979 Abdominal mass Left ovary 
10 Cystic 
months 130mm 
2 yrs 1%5 Abdominal Cystic 
distension 100mm 
9yrs& 1994 Abdominal pain Right ovary 
6 50mm 
months 
2 yrs 1994 Acute torsion Left ovary 
Cystic 
100mm 
lOyrs& 1991 Abdominal mass & Cystic 
11 acute torsion 120nun 
months 
3 yrs& 19~3 Abdominal mass Cystic 
8 74mm 
months 
3 yrs 1991 Abdominal mass Right ovary 
Cystic 
120mm 
7 yrs 1991 Abdominal mass Right ovary 
Cystic 
110mm 




GONADAL GERM CELL TUMOURS. 
OVARIAN GERM CELL TUMOURS OF CHILDHOOD. 
A) MALIGNANT. 
I) Ovarian germ cell tumours with a yolk sac component. 
Incidence 
In the current study 6 (11,5%) of 52 childhood ovarian germ cell tumours contained a yolk sac component. 
Incidence figures from other childhood studies: 
- 1:9] Hanns & Janig - 12 (24%) of 50 ovarian g.c.t. contained a yolk sac component. 
- [D] Marsden et al - 7 (15,5%) of 45 neoplasms contained a yolk sac component. 
The mean age in the current study was 8 years 10 months - (range: 7 years 8 months to 12 years 6 months). 
By comparison, the mean ages for the other ovarian g.c.t. were: 
- Mature teratoma - 5 years, 6 months. 
- Immature teratoma - 7 years, 9 months. 
- Dysgerminoma - 10 years. 
- The single patient with a choriocarcinoma was 7 years of age. 
Clinical Presentation 
Adequate data was available for 5 of the 6 cases. Four presented with abdominal enlargement (2 of these patients had 
associated pain). In one case abdominal pain alone appeared to have been the symptom precipitating consultation. 
1:5, 7l Yolk sac tumours of the ovary are almost always unilateral, bilateral involvement being a manifestation of 




In the large series (71 patients. 29 premenarchal) of Kunnan & Norris [7] the median tumour diameter 
was 15cm. with a range from 7 to 28cm. 
In the current childhood study the mean tumour diameter was 12, 7cm, with a range from 11 to 17cm. 
(20) 
Tumour consistency 
In the present study, the data was unfortunately inadequate in virtually all the 6 cases. 
In the literature 11, 5, 7, 6] these tumours are described as being predominantly solid, \\1th a variegated cut 
surface, showing foci of haemorrhage, necrosis, and cystic degeneration. Capsular rupture, before or during 
operation occurs in approximately 30% of patients m. 
In the current study capsular penetration was documented to be present in 4 (66%) of the cases. 
Microscopic Pathology 
In the current study of 6 childhood ovarian neoplasms with a yolk sac component, the histological subtypes were: 
- Pure yolk sac tumour - 2 cases (33%). (The one showed no predominant histological pattern, whilst in 
the others a reticular pattern predominated). 
- Mixed yolk sac tumour/immature teratoma - 3 cases (50%). 
- Yolk sac tumour with a possible embryonal carcinoma component - 1 case (16%). 
Comparison with other childhood series: 
Harms & Janig l:S] - 12 ovarian tumours with a yolk sac component - 7 (58%) pure, 5 (42%) mixed. 
Hawkins et al [i5] - 13 ovarian tumours with a yolk sac component - 7 (54%) pure, 5 (38%) mixed 
YST/teratoma, 1(7%) mixed YST/embryonal carcinoma. 
Clinical Outcome 
Results from current study compared to other childhood series. 
Study Total No. Of Cases Death Alive with residual Alive, No residual 
with a Y.S. T. Disease Disease 
Comnonent 
Current Studv 6 2 (33%) 1 (16,6%) 3 (50%) 
Hawkins et al [!SJ 13 3 (23%) 0 10 (77%) 






Kurman & Norris m found some correlation, albeit not statistically significant, between tumour size and 
outcome. In the current study no such tendency was apparent (see detailed table) 
Microscopic 
In the study ofKurman & Norris m, as well as that of Hawkins et al [!5], no microscopic feature (such as 
histologic tumour pattern or mitotic activity) correlated with survival. The current study, similarly showed 
no correlation ( other variables, additionally evaluated - microscopic necrosis, vascular invasion, and 
anaplasia). 
Type of therapy administered - In the current series the 2 patients who died were diagnosed at an earlier 
date in the study than the survivors, and neither received multidrug chemotherapy. 
(22) 
II) Ovarian Dysgerminomas of Childhhood. 
Incidence 
In the current study 6 (11.5%) of 52 childhood ovarian g.c.t. were dysgerminomas. 
Comparison with other childhood series: 
Study Total No. Of ovarian G.C.T. 
Current Study 52 6 
Marsden et al [D] 45 
Harms et al 1:9] 50 
Breen et al ["] 674 
(literature review) 






In the current study the mean age was 10 years (range 7 to 14 years) i.e. greater than that for the other ovarian germ 
cell tumour types. 
Clinical presentation 
Data was available for 5 of the 6 cases. 
- In 3 patients the primary presenting symptom was abdominal enlargement. 
- In 1 patient abdominal pain. 
- And 1 patient presented initially with a manifestation of metastatic spread, namely an enlarged 
supraclavicular lymph node. Ovarian biopsies at this stage showed no evidence of neoplasia, however 12 
months later a large ovarian tumour was present. 
Macroscopic pathology 
In the current study all the tumours were unilateral, the right ovary being involved in five cases and the left in one. 
Dysgerminomas are typically large, bossellated tumours, with a homogenous, solid, grey coloured cut surface ( often 
described as having brain- like consistency). [1, "] 
In the current study data was available for only 3 of the 6 cases, all of which were described as being solid. The 
maximum tumour diameters were - 80, 90, and 150mm respectively. 
(23) 
Microscopic Pathology 
Salient findings in current study: 
- Granulomatous inflammation could be detected in only 2 of the 6 cases. 
- Syncytiotrophoblastic giant cells were not detected in any of the cases. 
- None of the neoplasms showed anaplastic foci. 
- The stroma of the one tumour showed marked oedema, resulting in a histological appearance strikingly 
similar to a reticular yolk sac tumour. 
Clinical Outcome 
Current Study - Follow up data was available on 5 of the 6 patients. Four were alive with no evidence of residual 
disease (follow up duration ranging from 2 months to 13 years). 
One was alive with residual disease. 
No deaths were documented, despite metastatic disease being present in 5 of the 6 patients. (Lymph node 
involvement occurring in 4, and omental disease in one). 
III) Choriocarcinoma 
Please see detailed tabulated data for information on the single patient with an ovarian choriocarcinoma. 
(24) 
B) IMMATURE OVARIAN TERA TOMAS 
Incidence 
Immature teratomas comprise only 1 - 2 % of all ovarian teratomas. however of those arising durin
g the first two 
decades of life. they account for 10 - 20%. [2] 
In the current series 9 ( 17%) of the 52 ovarian germ cell tumours were immature teratomas, whilst 
considering 
teratomas alone. 23% were immature. 
Immature ovarian teratomas occur predominantly in the first two decades of life, with a peak incide
nce at 14 - 19 
years. [1] 
In the current study, which included only paediatric patients. the mean age was 7 years 9 months (
Range : 2 years 6 
months to 12 years 6 months). 
Clinical Presentation 
Abdominal enlargement (readily palpable tumour), with/without accompanying pain is the usual m
ode of 
presentation. ll] In the series of Nogales et al [71] all 20 of the patients presented with abdomi
nal enlargement 
(40% had accompanying abdominal pain), similarly 80% of the 58 patients in the series of Norris 
et al [%] (which 
included all age groups) had abdominal enlargement, 44% accompanying pain. 
Current study. abdominal pain was the primary symptom precipitating admission in 7 (87%) of the
 8 patients with 
adequate clinical data. Acute torsion occurred in at least 3 instances. (As the smallest tumour me
asured 11cm in 
diameter. it is likely that all the patients had at least some degree of abdominal enlargement, althou
gh this was not 
stated clearly in the clinical notes). 
Macroscopic Pathology 
Immature ovarian teratomas are almost always unilateral. [2] Only one of the 58 cases reported b
y Norris et al [%] 
was bilateral. In the series of Nogales et al [72:] none of the 20 cases were bilateral. (No predile
ction for any one 
side has been documented). 
Current study. all 9 cases were unilateral. 
The majority of tumours have both solid and cystic components. [", 2, %] 
The mean tumour diameter. in various series, ranges from 150mm ( l5~] Kooijman) to 200mm ( [
72:] Nogales et al). 
(25) 
Current study, 4 of the 8 cases with adequate data were reported as being purely cystic - a finding somewhat at 
variance with the reported literature (see above). The other 4 cases were ofa mixed solid- cystic consistency. 
The mean tumour diameter in the current study was 153mm (range: 110-260mm) Capsular penetration was 
documented in 2 (25%) of the cases. 
Histopathology 
The tumours were graded from l - 3, according to the criteria ofThurlbeck & Scully [77] (1960). 
Total number of ovarian immature teratomas in current study - 9. 
- Grade 1 - 4 (44%) cases. 
- Grade 2 - 3 (33%) cases. 
- Grade 3 - 2 (22%) cases. 
The series ofKooijman 1:.591 (8 patients), which like the present study evaluated only childhood cases, showed 
similar findings 
- grade 1 (50%), grade 2 (25%), grade 3 (25%). 
Whereas in the series of Nogales et al rm plus Norris et al [%] both of which involved predominantly post 
menarchal patients, grade 2 tumours were the most frequent. 
The immature neuroepithelial tissue, which was present in all 9 of the cases, included: 
- Neuroepithelial rosettes (Homer-Wright or Flexner Winterstein in type) - seen in 7 cases. 
- Solid sheets resembling neuroblastomatous foci - present in 5 cases. 
- Immature neuroglial - seen in 4 cases. 
Non neuroepithelial immature tissue was noted in only 2 cases, the one having immature mesenchyme and the other a 
rhabdomyoblastic component. 
With regard to the relationship between tumour grade and other histological variables (see also accompanying table): 
- A mitotic count of :s; 5/10 H.P .F. occurred in all four grade l tumours, however one of the grade 3 
cases similarly showed a low mitotic rate (1/10 H.P.F.) 
- Microscopic necrosis was present in both grade 3 cases, however one of the grade 1 cases also showed 
scanty necrosis. 
- None of the tumours demonstrated vascular invasion (although intravascular glial nodules were noted 















































































































































































































































































































































































































Results from current study: 
Tumour Grade Total Number of Death Alive with residual 
Alive, No Disease. 
cases disease 
I 2* 0 0 2 
II 3 l** 0 2 
III 2 0 l*** 1 
* 4 Grade I teratomas were included in the study, however only 2 of the patients had adequate fol
low up data. 
** Clinical course characterised by extensive peritoneal metastatic deposits. 
*** Histology of the peritoneum showed glial nodules, predominantly well differentiated, within 
blood vessels 
(see discussion later, under gliomatosis peritoneii) - unfortunately, only 3 months follow up data w
as available 
on this patient. 
The finding that death occurred in only l (14%) of 7 patients, is similar to that ofKooijman's [5~] 
series (which 
also evaluated only paediatric patients), in which all 8 patients survived. 
The mortality figures from series which include predominantly post memarchal patients are howev
er significantly 




- Nogales et al [72] - 21 % mortality rate. 
Norris et al I:%] found a degree of correlation between the maximum diameter of immature ovari
an 
teratomas and prognosis. In their series all patients with tumours less than 10cm in maximum diam
eter were 
alive and well, in comparison to 67% with tumours 10 to 19,9cm, and 54% with neoplasms 20cm 
or greater. 
In the current study, the 2 patients with the largest neoplasms (23cm. and 26cm. in diam. respectiv
ely) 




Nogales et al [72] found capsular rupture to be an important prognostic feature. Seven of 9 patie
nts with 
rupture developed peritoneal implants of varying histologic grade, two of whom subsequently died. 






Tumour grade has been shown in a number of studies (especially those involving post menarchal
 patients) to 
be of prognostic significance (see table below): 
Correlation between grade o(immature ovarian teratoma and mortality rate. 
Stud'\' Grade 1 Grade 2 Grade
 3 
** Norris et al [%] 
- % Mortality rate 18 38 
70 
- (no. of deaths/total (4/22) (9/24) 
(7/10) 
no. of cases). 
** Nogales et al [72] 
- % Mortality rate 0 11 
60 
- (no. of deaths/total (0/6) (1/9) 
(3/5) 
no. of cases). 
** lhara et al [ij(lJ] 
- % Mortality rate 0 0 
33 
- (no. of deaths/total (0/2) (0/1) 
(1/3) 
no. of cases). 
* Kooijman £.59] 
- % Mortality rate 0 
- (no. of deaths/total (0/4) 
no. of cases). 
* Current study 
- % Mortality rate 0 
- (no. Of deaths/total (0/2) 
no. Of cases 
* * - Patient population predominantly post menarchal. 







One of the two grade 3 patients developed tumour recurrence. 





As commented previously, a striking difference is noted in the mortality rate between those studie
s including 
predominantly post menarchal patients (22 of82 patients i.e. 33%) as opposed to those involvin
g 
exclusively paediatric patients (1 of 15 i.e. 6,6%). 
Given the apparent favourable outcome of most paediatric patients with immature ovarian teratom
as, tumour 
grade would appear to be of less prognostic significance in this group. However, as demonstrated
 in the 
table, a problem free clinical course can be expected with grade I neoplasms. 
Nature of non neural immature tissue 
In the current study a rhabdomyoblastic component was present in one neoplasm, and a focus of 
immature 
mesenchyme in another. Both patients had uncomplicated clinical courses. 
(28) 
Note on gliomatosis peritoneii and immature ovarian teratomas. 
Approximately 10% of patients with immature ovarian teratomas develop peritoneal im
plants composed exclusively 
of mature glial tissue - "gliomatosis peritoneii". [2J The biological behaviour of the
se implants is benign, and 
additional therapy is not indicated. The lesions are thought to usually result from caps
ular rupture and consequent 
implantation of neoplastic tissue (either mature, or immature with subsequent maturat
ion). Some authors (Robboy 
& Scully 1970, £751, EL Shafie et al 1984, [1031), have suggested that lymphatic spread
 may also have a role. The 
finding of well differentiated glial nodules in peritoneal vessels, in one of our cases, wo
uld support this hypothesis 
(See photograph below). 
Fragment of omentum showing numerous well differentiated glial nodules, some of wh
ich are located within blood 
vessels. 
(29) 
C) MATURE OVARIAN TERATOMAS 
Incidence 
In the current study 30 (57, 7%) of 52 childhood ovarian g.c.t. were mature
 teratomas. 
Comparison with other childhood series: 




Marsden et al [IJJ 45 
25 (55,5%) 
Harms et al ~l 50 
19 38% 
Breen et al ["1 674 
387 (57,4%) 
<Literature review) ;.;;.;~;.;.. ______ ...,__ _______
____ ...i.... __________
__ _. 
The mean age of the patients in the current study was 5 years 6 months (ra
nge 3 weeks to 12 years). 
Noteworthy remarks in comparison with: 
- Yolk sac tumours + dysgerminomas - in both these groups, the youngest patient was 7 yea
rs of age. 
(18 of the 30 mature teratomas occurred at an earlier age). 
- Immature teratomas -youngest patient 2 years 6 months (6 of the 30 mat
ure teratomas occurred at an 
earlier age). 
Clinical Presentation 
- No clinical data was available in 5 of the JO cases. 
- Abdominal distension was the primary presenting complaint in 15 (As an emb
ryonic migrant from the 
area of TIO, the ovary in early life is characteristically abdominal in location, desc
ending at puberty into the 
bony pelvis ["1). 
- Abdominal pain as the primary presenting symptom occurred in 9 patients (7 o
f the 9 having acute 
torsion - it has been suggested that the abdominal location of these tumours, s
ee above, results in elongation 
of the ovarian pedicle, and predisposes to adnexal torsion ["1). 
- One patient presented with recurrent urinary tract infections. 
(30) 
Macroscopic Pathology 
While 25% of mature ovarian teratomas reportedly are bilateral in adults {"1, in children most are unil
ateral -
estimates ofbilaterality in children ranging from 0-9% Il05, I0'1. 
In the current study only 1 (5,5%) of the 18 cases with adequate data was bilateral. 
Size - In the current study the mean size was 86mm (range 22mm to 130mm). By way of comparison, t
he 
mean diameter of the yolk sac tumours and immature teratomas were 127 and 153mm respectively. 
Consistency - All 27 of the cases with adequate data were of a cystic nature ( either unilocular or 
multilocular). 
Microscopic Pathology 




BREAKDOWN OF 1ESTICULAR G.C.T. EV ALUA1ED IN THE CURRENT STUDY. 
A) Malignant 
I) With a Y.S.T. component (but excluding 
those with a definite or possible embryonal 
carcinoma component) 
II) With a Y.S.T. component plus a possible 
embryonal carcinoma component 
III) With a definite embryonal carcinoma 
component 
IV) Seminoma 
Total no. Malignant testicular g.c.t. 
B) Immature teratomas 
C) Mature teratomas 
Total number childhood testicular g.c.t. included in study 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TESTICULAR MATURE TERA.TOMAS 
Year Age (Months) Side involved Clinical Size (max diam Tumour histology Follow up 
presentation inmm) 
1985 14 L T~iicular 40nnn Mlllllre tenuoma No follow up 
swclline Multicvstic 
1962 48 ? ? '! .Mature tmuoma No follow up 
1973 36 R Teh1icular mas~ 30mm Mature temtoma Alive well at 
Encap$ulated 4\.iye;in. 
cvstic 




TESTICULAR GERM CELL TUMOURS OF CHILDHOOD. 
Incidence 
Testicular tumours are said to account for between 3% to 7% of all childhood germ cell tumors rn. !~. rt ml 
In the current study, 22 (12,5%) of the 176 germ cell tumours were of testicular origin. 
Age and relationship to tumour histology 
Testicular germ cell tumours may occur at any age, from birth to the 6th decade and beyond. The frequency of the 
various histological types does however differ markedly in children and adults. 
In adults the tumours are more commonly of mixed histological type (approximately 62% mixed and 38% pure) ~], 
whereas in children the vast majority are pure in type. 
In adults seminomas account for approximately 70%, and yolk sac tumours 6% of the pure tumours, DA,] whilst in 
children the converse is seen - yolk sac tumours being by far the most common single histological type, and 
seminomas extremely rare. 
In the current study, of the 22 testicular g.c. tumours: 
16 (72,7%) contained a Y.S.T. component (13 pure Y.S.T., 2 Y.S.T. with possible embryonal components, and 1 
mixed Y.S.T./mature teratoma). 
- 4 (18%) were mature teratomas. 
- and 1 case each of pure embryonal carcinoma and pure seminoma. 
(It is of note that no immature teratomas occurred). 
The pathogenesis of adult and childhood testicular g.c.t. would appear to be different. Intratubular germ cell 
neoplasia being identifiable in 85 - 100% of adult cases, but absent in those occurring in childhood. In the current 
study no evidence of ITGCN was identifiable in any of the cases. (lmmunohistochemistry for placental alkaline 
phosphatase was however not employed). 
Predictors of clinical outcome/prognostic factors in malignant testicular GCT. 
A) Y.S.T. - The vast majority of malignant testicular g.c.t. in children are yolk sac tumours. [5.Sl 
Where these tumours are localized to the testis and occur in early childhood the prognosis is favourable l.9. 
2] (unlike the outcome in adults). 
Harms et al [SJ evaluated 22 children with testicular yolk sac tumors 
- 18 with pure YST (mean age 23,7 months; range 0-104 months) and 4 with mixed g.c.t with a Y.S.T. 
component (mean age 186 months; range 177 - 192). No deaths occurred, 2 of the children from the pure 
Y.S.T. group were alive with residual disease, all 20 of the remaining children were alive and free of disease. 
In the current study the outcome data was as follows: 
- Pure Y.S.T. 13 cases (mean age 13,8 months; range 2 - 36 months) - no follow up data was avail-
able on 3 patients - all 10 of the remaining children were alive with no evidence of residual disease 
(follow up duration ranging from 6 months to 15 years). Nine of the ten patients had Stage I disease, 
and only 1 child with involved intra-abdominal lymph nodes had stage II disease. An additional patient sustained 
a scrotal recurrence 2 months after the original surgery. 
(33) 
- Mixed mature teratorna/Y.S.T. - Only one case, that ofa 17 month infant was included in the study. 
He presented with stage I disease, however 6 months later developed marked hilar lyrnphadenopathy. 
Following chemotherapy, he remains well 11 Yz years later. 
B) Y.S.T. with possible embryonal carcinoma component (occasional solid areas showing prominent 
nuclear pleomorphism and containing scanty numbers of syncytiotrophoblasts - unclear whether to 
classify as embryonal carcinoma or solid pattern of a yolk sac tumour) - Two such cases were 
included. The one, a 14 month infant, presented with disseminated disease, including pulmonary 
metastases. Follow up notes extended only to 8 months, at which time he was alive and well 
(disease status unclear). The other a 24 month infant presented with stage I disease - unfortunately 
no follow up data is available. 
C) Pure embryonal carcinoma - Only one case identified, occurring in a 5 year old child who 
subsequently died from disseminated disease non responsive to chemotherapy. This was the only death 
amongst the patients with testicular tumours. 
D) Pure seminoma - Only a single case, occurring in a 6 month old infant, was identified. 
Unfortunately, no follow up data was available. 
Evaluation of possible histological prognostic indicators. 
1. Regarding pure Y.S.T. - Vascular invasion which has been shown in adults with stage I disease to be of 
prognostic importance, could not be identified in any of our cases. 
- Mitotic count did not appear to be of significance; the only patient with stage II disease having a count of 
less than 1/10 H.P.F. 
- Of the 6 patients with microscopic necrosis and adequate follow up data, 4 had stage I disease with no 
tumour recurrence, 1 stage I disease with scrotal tumour recurrence, and 1 stage II disease. The remaining 
5 with no microscopic necrosis (and adequate follow up data) all had stage I disease with no recurrence. The 
significance of these findings requires a larger patient sample for evaluation. 
- Anaplasia was identified in a single patient who had stage I disease and no tumour recurrence. 
2. Regarding the 3 patients with a possible/definite embryonal carcinoma component, both vascular invasion and 
anaplasia were documented in two, one of whom died from disseminated disease, whilst the other developed nodal 
and pulmonary metastases (final disease status unclear). In both adults 1:.2'1 and children rn.3] embryonal 
carcinoma has been shown to behave in a more aggressive manner (than testicular Y.S.T.). 
Concluding remarks regarding the prognosis of childhood malignant testicular g.c.t. 
1. The excellent prognosis of stage I pure Y.S.T. in early childhood (less than 2 years of age) was confirmed 1:.9, 1121 
2. With regard to pure Y.S.T. - Mitotic count and anaplasia were not found to be of prognostic value, nor was any 
specific histological tumour pattern. 
- Microscopic tumour necrosis was found to be of possible prognostic significance, and further investigation 
appears warranted. 
- Vascular invasion could not be identified in any of the cases. 
3. Although the number of cases involved were few, a definite/possible embryonal carcinoma component appeared to 
confer an adverse prognosis. 
Other testicular g.c.t. 
No cases of immature teratoma were identified ( 1:59] Kooijman, similarly found immature testicular teratomas of 
childhood to be rare - accounting for 2 (5,5%) of 36 testicular g.c.t. 
Four cases of mature teratoma were documented (see tabulated data). 
(34) 
EXTRAGONADAL GERM CELL TUMOURS 
BREAKDOWN OF SACROCOCCYGEAL G.C.T. EVALUATED IN THE CURRENT STUDY. 
A) Malignant 
I) With a Y.S.T. component 
II) Embryonal carcinoma (definite or possible) 
III) Germinoma 
IV) Choriocarcinoma 
Total no. Of malignant sacrococcygeal g.c.t. 
B) Immature Teratomas 
C) Mature Teratomas 
Total number of childhood sacrococcygeal g.c.t. included in study. 









(One immature teratoma, plus one mature teratoma subsequently recurred with a yolk sac tumour component - both 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































EXTRAGONADAL GERM CELL TUMOURS 
SACROCOCCYGEAL GERM CELL TUMOURS 
57 Sacrococcygeal germ cell tumours were included in the study; 
- 15 Malignant (having a yolk sac tumour component) 26,3%. 
- 15 Immature teratomas 26,3%. 
- and 27 Mature teratomas 47,4%. 
2 Patients had benign germ cell tumours (mature teratorna and Grade III immature teratorna respectively) which 
recurred as yolk sac tumours - both the primary and the recurrent malignant tumour are included in the statistical 
data. 
In comparison with the other series, (see below), the percentage of malignant cases is significantly high. 
Histologic classification ofsacrococcygeal G.C. T. (%). 
Series Benion/Mature Immature Malionant 
V aldiserri et al [l[I 75 11,8 13,2 
Berry et al [m 63,8 24,1 12,1 
Mahour et al 1:92] 66,7 19,4 13,9 
Gonzalez-Crussi et al [~[I 55 27,5 7,5 
Noseworthy et al [47] 66,1 16,2 17,7 
Current Studv 47 4 26 3 26 3 
(36) 
Analysis of clinical features. 
In all studies there is a remarkable predilection for females (see below). No satisfactory explanation has been 
hypothesised. 
















These results are strikingly similar to those found in a number of other studies. 
* Insufficient data was available for 2 cases of mature teratoma. 
Author No. Of sacrococcveeal G.C. T. 
Conklin et al ( 1967) [~S] 32 
Waldenhausen et al (1963) [SO] 111 
Gonzales - Crussi et al ( 1978) [~i] 40 
V aldiserri et al ( 1981) [li] 68 
Noseworthy ( 1981) [~7] 118 
Berry et al ( 1969) [ii] 58 









All published studies are in agreement that increasing age, beyond the newborn period, increases the risk of 
malignancy several fold. [~], [5Sl, [SlOJ], [~!], UJ], [~S] 
Data from other series: 
- Valdiserri et al [li] - 89% of their malignant tumours occurred in infants older than 4 months. 
- and 80% of their patients with mature teratomas were less than 4 months of age. 
- Noseworthy et al [~7l - Average age of malignant tumours - 21 months. 
- Average age of mature + immature teratomas - 2 Days. 
- Berry et al [Ill - None of 46 tumours detected before 1 year of age was malignant. 
- Whereas 4 of 12 detected after 1 year of age were malignant. 
- Harms et al [S] - None of 11 malignant tumours occurred in patients less than 17 months. 
(37) 
Current Study 
Mature Teratoma* Immature Teratoma Mali1mant {Yolk sac 
tumour} comJ!onent 
nresent 
% Of cases oresent at birth ** (19/24) 79,1% ** (15/15) 100% *** (2/15) 13% 
Mean age of other cases l6Y2 weeks - 25,2 months 
Range of other cases 3 weeks -+ 30 weeks - 3 months -+ 60 months 
* Data was lacking for 3 cases of mature teratoma. 
** One tumour from each of these groups recurred 24 months later with a yolk sac component. 
*** An additional 2 tumours which had been diagnosed as non malignant (mature and immature teratoma 
respectively) at birth, recurred at 24 months of age with a yolk sac component. 
Comment on the above findings. 
1. Mature and immature teratomas - 89% of these were diagnosed at birth, 100% by 7
 Y:z months of age - findings 
consistent with the previously published literature. (Although all the benign/imma
ture neoplasms in this study 
were diagnosed prior to one year of age, presentation in older infants/children, even
 up to several years of age, is 
certainly well described) [2, il 
2. Yolk sac tumour component present - 13% of these were diagnosed at birth, and 20
% by 3 months of age (the 
remaining 80% beyond 16 months of age). The early onset of 20% of the yolk sac tum
ours in the current study, is 
at variance with much of the previously published literature (see above rn. 91 ), emphasising the requirement for 
accurate histological diagnosis in all cases, independent of age. 
Clinical Presentation 




(Post/retrosacral or extrapelvic) - The tumour grows posterior or superficial to the
 sacrum and coccyx. This 
is the most common growth pattern and is usually associated with a benign course. 
[~] 
Dumbbell shaped gro\\ths with roughly equal presacral (intrapelvic) and post sacra
l (extra pelvic) 
components. Approximately 6% of these are said to have metastases when first diagn
osed. [~] 
Assymetrical dumbbell growths with predominance of the presacral (intra pelvic) c
omponent. Although far 
less common than the above preceding types, approximately 20% are said to have metasta
ses at diagnosis. 
[~l 
Entirely presacral (intra pelvic). 8% are said to have metastases at diagnosis. [~] 
(38) 
Tumours with a predominant post sacral growth pattern generally present with an obvious buttock mass, which may 
be of prodigous proportions ( occasionally weighing as much as the attached infant! ! ) . 
Whilst those with a predominant presacral growth pattern may present with: 
- An abdominopelvic mass. 





Tumour Type Insufficient Number Buttock Mass Abdomino- Urinary tract Bowel 
data evaluated oelvic mass obstruction obstruction 
Mature tera- 7 19 *17 2 0 
toma 
Immature 3 11 **10 1 0 
teratoma 
Malignant 1 ***14 *8 5 3 
**** 
* One patient had a presacral component, in addition to the presenting postsacral component. 
** Four patients had a presacral component, in addition to the presenting postsacral component. 
*** The two patients who presented with benign lesions which later recurred as yolk sac tumours have been 
evaluated here with the malignant group. 
**** In the malignant group some patients presented with more than one feature. 




- 27 (90%)/30 patients with mature/immature sacrococcygeal teratomas had post sacral presentations - a finding 
consistent with that of other studies [U, ~l 
- With regard to the patients with sacrococcygeal Y.S.T., pre - and post sacral presentations occurred with approxi-
mately equal frequency (a finding somewhat at variance with the previously published literature in which a 
pre sacral mode of presentation is said to be commoner). 
(39) 
Macroscopic Pathological findings 
Tumour Size 




* Tumour type No. Of cases with No. Of cases Mean Range 
insufficient data evaluated 
Mature teratoma 2 25 75 30 to 130 
Immature teratoma 1 14 106 50 to 160 
Mali!mant (YST) ** 10 3 98 50 to 135 
* With regard to the benign tumours which recurred as malignant lesions. the data from the original lesions have 
been included in their respective benign categories. 
** Many of the malignant tumours could not be excised in their entirety. 
Comment on the above findings 
Considerable overlap exists between the sizes of the mature, immature and malignant lesions. These results are 
consistent with the findings of Gonzalez - Crussi [4[1 : "Size of the tumor (sacrococcygeal) had no bearing on 
prognosis". 
Clinical Outcome Synopsis 
I) Cases containing a yolk sac tumour component 
Total No. Of cases 
Insufficient follow up data 
No. Evaluated 
No. Of deaths 
No. Of survivors who developed metastatic disease 
No. Who either died or developed metastatic disease 
No. Alive but with residual disease 











Comment on the above findings. 
The highly malignant nature of sacrococcygeal yolk sac tumours was confirmed. The poor outcome being simil
ar to 
that found in other series (see below). 
Series No. Of sacrococq~al !Olk sac No. Of deaths 
tumours 
1967 Conklin et al [59] 7 7 (100
%) 
1978 Gonzalez Crussi et al [~[! 7 6 (85,7
%) 
1981 V aldiserri et al [2[1 9 9 (100%) 
1986 Hawkins et al [1.5] 26 10 (38,5%) 
Current study 12 (with follow up data) 6 (50%) 
II) Immature teratomas 
Total No. 
Insufficient follow up data 
No. Evaluated 
No. Of tumour related deaths 
No. Of recurrences 
No. Of non tumour related deaths 
No. Of patients alive with no disease 







4 (out of 5)** 80% 
0 
* Same patient in both instances (recurrence and death secondary to yolk sac tumour). 
** Excluding the non tumour related death. 
(41) 
COMPARISON OF RESULTS ABOVE WITII OTIIER SERIES (EVALUATING IMMATURE TERATOMAS OF 
TIIE SACROCOCCYGEAL REGION). 
3 Cases-No * 2 cases 
complications. Tumour recurrence 
of same or lower 
de- 1 case. 
Noseworthy et al 18 5 cases 8 cases 5 cases 
{47l Recurrence as Recurrence as Recurrence as 
malignant g.c.t. - 1 malignant g.c.t. - 1 malignant g.c.t. - 1 
case. case. case. 
Tumour recurrence 
of same or lower 
de - 1 case. 
Valdiserri et al (20 8 ** 2 cases 4 cases 
No complications. No complications. 
Kooijman £59) 6 Recurrence as 
malignant g.c.t. - 2 
cases (Grade I and 




of same or lower 
grade - 1 case 
(Grade IT immature 
teratoma). 
Metastatic immature 
teratoma - 1 case 
(Grade II tumour 
with hepatic 
metastases -
themselves of Grade 
I histological 
a ce.) 
Berry et al ao 14 Recurrence as 
malignant g.c.t. - 4 
cases. 
Current Study 6 *** 2 cases - No 3 cases. 1 case - No 
complications. Recurrence as malignant complications. 
g.c.t. - 1 case**** 
(42) 
Footnote: 
* In this study 10 cases were classified as Grade III immature teratomas - however 7 of these contained yolk sac 
tumour elements, and one features consistent with an "adenocarcinoma". The latter 8 cases have thus been 
excluded from the tabulated data. 
** In 2 cases the immature tissue was entirely of renal origin (both these cases had uncomplicated clinical courses). 
*** Only 6 of the 15 cases ofsacrococcygeal immature teratomas had adequate follow up data. 
**** Although the recurrence of benign sacrococcygeal teratomas as malignant lesions is well documented, see 
tabulated data above, plus the study of Hawkins et al H5], this case dates back to 1961, at which time it was 
not standard protocol to take at least one tissue block per centimetre of the maximum tumour diameter. 
Inadequate sampling of the original tumour specimen can thus not be excluded. 
Comment regarding the data on the 60 cases of sacrococcygeal immature teratoma reviewed above. 
1. Recurrence as a malignant g.c.t. was documented in 10 (16,6%) of the 60 immature teratomas. The question 
whether some (or even all) of these could have been malignant de novo is purely conjectural, and cannot be 
answered with any forthrightness. In any event, the need for early, complete excision (including coccygectomy) of 
all sacrococcygeal g.c.t. cannot be overemphasised. Similarly, adequate sampling by the pathologist, of all such 
excised lesions, is mandatory. 
2. Tumour recurrence, as a teratoma of the same/lower grade occurred in 5 (8,3%) of the 60 cases. 




Absent follow up data 
No. Evaluated 
No. Of tumour related deaths 
No. Of recurrences* 
No. Of non tumour related deaths** 
No. Alive with no residual disease 
No. Alive with residual disease 
* Recurrence as yolk sac tumour. 
** Death secondary to septicaemia. 








6 (out of6***) 
0 
COMPARISON OF RESULTS (MATURE SACROCOCCYGEAL TERATOMAS) WITII OTIIER SERIES. 
Gonzalez - Crussi 22 4 0 
Conklin et al £831 19 1 0 
Be et al £10 41 1 3 
Current Stud 7* 0 l 
* Additional 20 cases identified but follow up data inadequate. 
(44) 
BREAKDOWN OF RETROPERITONEAL G.C.T. EVALUATED. 
A) Malignant 
I) With a yolk sac tumour component 
II) Embryonal carcinoma 
Total no. Of malignant retroperitoneal g.c.t. 
B) Immature Teratomas 
C) Mature Teratomas 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































RETROPERITONEAL GERM CELL TIJMOURS OF CHILDHOOD .. 
Incidence 
These uncommon tumours account for approximately 4% of all childhood g.c.t. rn. 12. 10. 131 
In the present study 12 retroperitoneal neoplasms were included, out of a total of 176 gonadal and extra gonadal g.c.t. 
ie 6, 7% of the total. 
Clinical features 
2. Sex 
In pre"iously published studies the patients have ranged in age from newborns to those in the 6th decade of 
life £93. '3. 4(J]. The average age in the series of Engel et al 1:9'1 (30 cases) was 16 years (with 43% 
being children less than 10 years of age), while that in the series of Lack et al ['31 (11 cases), 18 months. 
In the current study the average age for all the cases was 23, 2 months (range birth to 12 years). Subdividing 
the patients according to tumour type, the average ages were: 
- malignant g.c.t. - 69 months (range 22 months to 144 months) 
- immature teratomas - 12 months (range 1 month to 54 months) 
- mature teratomas - 5,3 months (range birth to 8 months) 
The increasing risk of malignancy with increasing age, seen in the current study, was not evident in those of 
Engel [%] and Lack et al ['31 
Engel and associates [%] in their review of previously published cases found a slightly higher incidence in 
males (M:F = 3 :2), whereas Lack et al ['3] found a strikingly higher occurrence rate in females, 10: 1. 
Current study F: M = 3:1. 
3. Clinical presentation 1:9,. ,3. ~] 
- Not infrequently the presenting manifestation is an asymptomatic increase in abdominal girth (noted 
during routine post natal follow up, or by the mother herself). 
- More commonly however, abdominal pain, nausea, vomiting and weight loss accompany the abdominal 
distension (thus raising the suspicion of gastrointestinal pathology). 
- Urinary tract symptoms appear to be surprisingly uncommon, given the close proximity of these tumours 
to the kidneys. 
- Constitutional symptoms related directly to the tumour are rare (low grade fever being occasionally 
reported). 




A) Macroscopic pathology [~. ,J] 
The tumours are usually of prodigous proportions - the average diameter in the series of Lack et al being 98mm. As 
with g.c.t. at other sites, the benign lesions are usually multicystic with a variable proportion of solid areas, whilst the 
malignant ones are predominantly solid, and apt to show foci of haemorrhage and necrosis. 
The findings in the current study conformed with the above (see tabulated data). 
B) Microscopic pathology 
Retroperitoneal g.c.t. are usually benign £.21 Review of the 11 g.c.t. in the series of Lack et al [~] shows 5 to be 
mature, 3 immature and 3 malignant (2 pure yolk sac tumours and 1 mixed immature teratoma/yolk sac tumour). 
Of the 30 cases studied by Engel and associates [%], 27 were benign and 3 malignant. Combining the 2 studies 
14,6% were malignant. The results from the current study (for details see tabulated data) show 3 mature, 6 
immature, and 3 malignant retroperitoneal g.c.t. (2 yolk sac tumors and 1 embryonal carcinoma). 
Of remarkable note in the present study, was the one immature teratoma which completely resembled a Wilms 
tumour, except for the immature neuroepithelial tissue at its periphery. (Of additional interest, 2 other immature 
teratomas contained small amounts of immature renal tissue). 
Prognosis 
Considering the 2 previously cited studies (Engel and Lack et al) 5 of the 6 patients with malignant g.c.t. died. 
In the current study the outcome for the 3 children with malignant neoplasms was similarly poor - 2 deaths plus 1 
patient alive with residual disease at 11 months (further follow up not available). 
Thus malignant retroperitoneal g.c.L like their counterparts in the sacrococcygeal region have an extremely poor 
prognosis. 
With regard to the 6 children with immature teratomas in the current study, none had metastatic disease on 
presentation. And of the 5 with adequate follow up data, all were alive with no evidence of residual disease 
(including the infant whose neoplasm resembled a Wilms tumour). 
(47) 
RENAL GERM CELL TUMOURS OF CHILDHOOD. 
Breakdown of Renal G.C.T. evaluated in the current study. 
A) Malignant 
B) Immature Teratomas 
C) Mature Teratomas 
Total no. Of childhood renal g.c.t. included in study 






GERM CELL TUMOURS OF THE KIDNEY (IN CHILDHOOD). 
Germ cell tumours arise very rarely within the kidney [.Wl Dehner reviewed the available literature up to 1973, 
only 2 cases had previously been described [m7l In 1978, Albert & Casamayou reported one case and reviewed six 
others [!Ol'll The few cases thus far described in children have had benign clinical courses (whereas in adults, 
there have been occasional case reports of malignant renal g.c.t. [.W]). 
Two cases of mature teratoma arising from the kidney are included in the present study - see tabulated data below: 
Age Sex Site Clinical Gross MicroSCOl!ic Follow DI! 
nresentation natholo2'' natholol!V 
4 months F Left kidney Abdominal Multicystic Mature No data 
distension with scattered teratoma-wide available 











13 months F Left kidney Abdominal Multicystic. Mature Well at 2 








BREAKDOWN OF MEDIASTINAL G.C.T. EVALUATED IN THE CURRENT STUDY. 
A) Malignant No. Of Cases 
I) With a yolk sac tumour component 
Total no. Of malignant mediastinal g.c.t. 
B) Immature Teratomas 2 
C) Mature Teratomas 8 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































MEDIASTINAL GERM CELL TUMOURS OF CHILDHOOD. 
Clinical Features 
Incidence 
Approximately 7% of childhood g.c.t. are said to occur in the mediastinum ul 
l l Cases of mediastinal g.c.t. are included in the current study - representing 6.2% of the total ( l 76 cases). 
Mediastinal g.c.t. have been detected from birth to the 6th decade (and possibly even beyond!). The mean age of the 
patients, in various series, depending entirely on the nature (adult-/childhood) of the population being studied £9~, 
97, IU. 
In the current study the average age was 32 months (range: birth to 13 years). 
There does not appear to be any sex predilection U, 4k\'l, Sll 
Current study F : M = 6:5. 
Clinical presentation 
- Up to 50% of children are asymptomatic - a mass lesion being discovered incidentally on Chest x ray. 
[2]. 
- Respiratory distress. cough and chest pain appear to be the most common presenting features. 
[l, 4k\'l] 
- Compression of structures other than the tracheobronchial tree may occur: 
- Oesophagus - dysphagia 
- Spinal cord - paraplegia 
- Superior vena cava - SVC obstruction 
- Sympathetic trunk - Homer's syndrome 
- Major vessel. especially pulmonary artery - acquired stenosis 
(As most tumours arise in the anterior mediastinum. the above features are far less common than those 
related to the tracheobronchial tree). 
- Rarely expectoration of hair and Keratinous material, or endocrinologic manifestations (hypoglycemia and 
precocious puberty. secondary to insulin and B HCG secretion respectively) may occur. 
In the current study, no data unfortunately was available for 6 of the 11 cases. The other 5 presenting with 
respiratory symptomatology - cough. stridor, recurrent chest infections; and/or chest pain. 
A) Gross Pathology 
As with g.c.t. at other sites, the benign lesions are predominantly cystic and encapulated; with the malignant being 
largely solid, non encapulated/infiltrative, and apt to show areas of haemorrhage and necrosis. 
The g.c.t. in the current study conformed to the above generalizations. There was no significant difference in size 
between the mature and immature tumours ( only one malignant neoplasm, which was treated with chemotherapy 
prior to surgery, was included in the study). 
(51) 
B) Microscopic pathology 
The histological finding in several studies are tabulated below: 







Hanns et al £SJ 7 1 (14%) 4 (57%) 2 (one Y.S.T. + 
one germinoma) 
(28% 
5 3 0 0%) 
16 10 
With regard to malignant germ cell tumours, all histological types (germinoma, yolk sac tumour, embryonal 
carcinoma, choriocarcinoma, plus combinations of these with each other, and with mature/immature teratomas) have 
been described as occurring in the mediastinum. Germinoma appears to be the most frequent malignant histological 
type [43. ,11. Yolk sac tumour, by contrast, rarely occurrs at this anatomical site - up until 1979 only 12 mediastinal 
cases had been reported 0001. 
Prognosis. 
1) Immature teratomas 
Carter et al C,,S] in 1980 reviewed the previously published literature on mediastinal immature teratomas. 
They found a striking relationship between age and prognosis. All 13 patients who were 15 years of age or 
older had died as a direct result of their tumours (which were locally infiltrative in 9, and gave rise to 
metastatic disease in 4). By contrast the 11 patients younger than fifteen, all survived, and were free of 
disease. 
In the current study the 2 infants with immature teratomas were likewise both well, with no evidence of 
residual disease. 
2) Malignant g.c.t. 
There is scanty literature on the prognosis of malignant mediastinal g.c.t. in children. In the 6 childhood 
cases reviewed by Hawkins et al 051, there were 3 tumour related deaths, 2 children were alive with no 
evidence of disease, and 1 child was lost to follow up. The only child included in the current study (mixed 
mature teratoma/Y.S.T) is alive and well with no evidence of disease at 8 years follow up. 
(In adults, the prognosis appears abysmal for non germinomatous malignancies - the 12 such patients in the 
series ofRecondo et al C,7] all died). 
3. Mature Teratomas 
The prognosis here largely being dependent on the skill of the surgeon and the quality ofperi-operative care. 
(52) 
BREAKDOWN OF PARA VERTEBRAL G.C.T. EVALUATED IN THE CURRENT STUDY. 
A) Malignant 
B) Immature Teratomas 
C) Mature Teratomas 
Total no. Of childhood paravertebral g.c.t. included in study 
PARA VERTEBRAL GERM CELL TUMOURS. 





Included in the study are 4 paravertebral g.c.t. (3 mature, and 1 immature teratoma). 
- See tabulated data below. 
Year Sex A2e Site Associated 
cone. 
anomalies. 





1981 F Birth Paravertebral Nil 
T2 - 8 area. 
1988 M Several Paravertebral Associated 
months meningocoele 
1989 ? ? Paravertebral Associated 
meningocoele 





















BREAKDOWN OF HEAD AND NECK G.C.T. EVALUATED IN THE CURRENT STUDY. 
A) Malignant 
I) With a yolk sac tumour component 
II) With an embryonal carcinoma component 
Total no. Of malignant head and neck g.c.t. 
B) Immature Teratomas 
C) Mature Teratomas 






Total no. Of childhood head and neck g.c.t. included in study 15 
(54) 
Footnote for table analysing G.C.T. of the head and neck. 
1. No metastatic spread, however extensive local infiltration occurred - through the mastoid sinus to reach the 
cerebellopontine angle. 
2. No metastatic spread, but extensive local infiltration, including into floor of mouth. 
3. The tumour was resected shortly after birth. At post mortem no obvious cause of death could be found. Nor was 
there evidence of disseminated disease. 
4. Cervical lymph node involvement - histology Grade m immature teratoma with neuroepithelial rosettes plus 
large neuroblastomatous areas. 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABULATED COMPARISON OF FINDINGS IN CURRENT STUDY WITH THAT OF OTHER SERIES: 
0 Mature Teratomas 
ID Immature Teratomas 
III) Malignant G.C. T. 
I) Mature Teratomas 
Illtiill~ ItllIII IllII~J.mlUlM@·t@Ulo.lOl.tc.B.ilIII@ lllllii-Iilll @Ktlmtt~Jlllli: 
Lack £.501 Neck 1 B/M N.E.D. 
Facial 3 B/2F/1M N.E.D. 
Orbital 2 B/lF/lM N.E.D. 
Nasopbaryngeal 1 B/F N.E.D. 
Orooharvneeal 1 B/M D.O.D. fll 
Berry CIO Neck 
Palate 










* Age - Refers to age at which the tumour was first noted. 
[l] - Teratoma irresectable, death from inanition. 
Abbreviations - N.E.D. - No evidence of disease. 
- D.O.D. - Death of disease. 
- B -Birth. 
B/2F N.E.D. 
B/lF No data 
B/3F/2M All patients well 
BIF post-operatively, but 
BIF no further follow up 
data available. 
BIF Local recurrence at 4 
years of age. 
Summary of information from tabulated data on childhood mature teratomas of the head and neck region ( excluding 
the CNS). 
Total No. 19 - All first noted at time of birth. 
- F : M = 2,1 : 1. 
- Location - Neck - 42%. 
- Facial - 22%. 
- Cervico-facial - 5,5%. 
- Orbit - 16,6%. 
- Oropharyngeal - 10,5%. 
- Nasopharyngeal - 5,5%. 
- Outcome - Follow up data available on 11, nine (81 ,8%) uncomplicated clinical courses, one death 
from irresectable oropbaryngeal tumour, one local recurrence (4 years later) of facial (cheek) 
teratoma. 
(56) 
II) Immature Teratomas 
¥Il!lll~ :ll1Ilt: tl:l:l:loo.&Tlo.N.llilf IlilffiMOltilistfflWMt P:l:lIIA.ffls.m.f.I@mmt lfilf&Ut¢.OMe.l!Il:l 
Lack £501 Neck 5 B/3F/2M N.E.D. 
Dehner [53] Neck 
Berty 00 Neck 
Palate 
Current Study Neck 
Nasopharynx 














Recurrence at 6 
months, currently 
N.E.D. 
1 case - No follow up 
data. 
1 case - Death post 
operatively. 
1 case - Alive and 
well 4 years and 10 
months later. 
N.E.D. (6 years 
follow up). 
Summary of information from tabulated data on childhood immature teratomas of the head and neck region 
(excluding the CNS). 
Total no. 12 - All first noted at birth. 
-F : M=l : l. 
- Locations - Neck - 83,3%. 
- Palate - 8,3%. 
- Nasopharynx 8,3%. 
- Outcome (data available on 11 cases) - Eight (72,7%) uncomplicated clinical courses, two (18,1%) 
post operative deaths, one (9%) local recurrence. 















Abbreviations - B - Birth 






















Yolk sac tumour -
death at 15 months. 
Y.S.T. - death, 1 
month later. 
Y.S.T. - death, 9 
months later. 
Y.S.T. - death from 
disease. 
Y.S.T. - Alive, no 
residual disease. 
Y.S.T. - Alive, free 
of disease. 
Y.S.T. -Two local 
recurrences, 




alive, no residual 
disease 4 years later. 
Y.S.T. -Alive 4 
months later, but 
disease status 
unclear. 
Y.S.T. - Local 
recurrence at 4 
months, further 
follow up not 
available. 
Summary of information from tabulated data on childhood malignant g.c.t. of the head and neck region (excluding 
the CNS). 
Total No. 10 - Age (when first noted) - Range from birth to 2Yi years. 
- Sex - F : M=4: 1. 
- Location - Oro/nasopharynx + mouth - 30%. 
-Neck-20%. 
-Head-20%. 
- Facial, submandibular, retro-auricular - 10% each. 
(58) 
GERM CELL TUMOURS OF THE HEAD AND NECK REGION (EXCLUDING THE C.N.S). 
I) Incidence 
Genn cell tumours in this region are uncommon. According to most authorities [~, 50, 53] they account for 
approximately 5% of all childhood g.c.t. 
Current study, 15 g.c.t. occurred in this region (head and neck excluding the CNS) representing 8,4% of the total 
number of cases. 
II) Sex 
Current study F : M = 2: 1. Using the data obtained from 3 additional studies rn, 5()), 531 (see comparative 
tabulated data). the ratio was similarly 2 : l (F : M). 
III) Clinical Presentation 
Age - Current Study: Mature teratomas - 8 cases - 6 from neck or cervico-facial region. 
- 1 from the cheek. 
- 1 orbital lesion. 
All present since birth. 
Immature teratomas - 4 cases - (3 cervical and 1 nasopharyngeal) -
all present since birth. 
Malignant tumours - 3 cases, respective location and age of presentation 
Lateral neck mass - 21 months. 
Submandibular mass - 24 months. 
Scalp - 5 months. 
Additional data, obtained from 3 other studies, similarly showed all the mature and immature teratomas to have been 
first noted at birth. The malignant lesions however tended to occur at a slightly older age - range from birth to 21/2 
years. 
The Clinical signs/symptoms are dependent on the location and size (the majority having already attained large to 
massive proportions by the time of birth). 
Foetal+ perinatal l:50, 5.l ~] problems include: 
- Polyhydramnios due to interference with foetal swallowing of amniotic fluid. 
- Non immune hydrops foetalis. 
- Dystocia (large neck masses causing hypcrextension of the head). 
Problems during infancy: 
- Neck+ pharyngeal lesions - Upper airways obstruction and consequent respiratory distress. 
- Dysphagia, leading to feeding difficulties + aspiration pneumonia. 
- Orbital lesions - External opthalmoplegia + blindness secondary to optic nerve compression. 
- Facial lesions - May cause distortion of facial bones. 
Current Study - For presenting symptoms/signs - see tabulated charts. 
(59) 
Histology, location, outcome. 
Evaluation of the data from the current study, plus three others rn, 5!11, 53], ie. a total of 41 g.c.t. of the head and 
neck region, showed: 
- Mature teratomas to be the most frequent histological type (46% of cases), followed by immature teratomas (29%), 
and malignant g.c.t. (25%). 
- With regard to mature and immature teratomas the neck was the most common location, 42% and 84,5% of these 
tumours. respectively. occurring at this site. 
- Malignant g.c.t. by contrast occurred with similar frequency in the oro/nasopharynx, neck and head. 
- The outcome of the mature and immature teratomas was excellent ,,ith only a single tumour related death 
documented. 
- By contrast 4 (50%) of the 8 infants with malignant tumours (and adequate follow up data) died as a direct result 
of their neoplasms. 
Case of note included in the present study (- data regarding this patient was published earlier by Dehner et al 1:53]) -
Of particular interest is the patient with a grade III immature teratoma of the neck who developed cervical lymph 
node metastases (mixture of mature and immature neural tissue). This gave rise to no long term consequences and 
the patient was well (free of disease) 4 years and l O months later, following surgical management alone. 
(60) 
SUMMARY OF DATA COLLECTED ON IMMATURE TERATOMAS OCCURRING IN CHILDHOOD. 
Location 
37 cases of immature teratomas were included in the present study. The table below reflects the sites of occurrence of 
these tumours, and draws a comparison with other childhood studies. 
N Of 0. 
. l . cases o immature teratoma at speci ic anatormca sites. 
Present Stud! Hanns and Janig £91 Kooijman £591 Utrecht2 
Cane Town. S.A. Kiel. Gennanv Holland 
Sacrococcygeal 15 (40,5%) 8 (26,6%) 6 (22,2%) 
Ovarian 9 (24,3%) 8 (26,6%) 8 (29,6%) 
Retroperitoneal 6 (16,2%) 3 (10%) 5 (18,5%) 
Neck (including 4 (10,8%) 2 (6,6%) 2 (7,4%) 
nasopharvnx) 
Mediastinum 2 (5,4%) 4 (13,3%) 1 (3,7%) 
Paravertebral soft tissue 1 (2,7%) 0 (0%) 0 (0%) 
Testicular 0 (0%) 4 (13,3%) 2 (7,4%) 
Other(unspecified) 0 (0%) l (3,3%) 0 (0%) 
Intra cranial 0 (0%) 0 (0%) 2 (7,4%) 
Gastric 0 (0%) 0 (0%) 1 (3,7%) 
Total 37 30 27 
Comment 
The sacrococcygeal region, plus the ovary, are the commonest sites of occurrence of immature childhood teratomas, 
followed by the retroperitoneum, mediastinum, neck and testis (in the current study however, no immature teratomas 
of testicular origin were documented). Less common locations include - central nervous system, stomach plus 
paravertebral soft tissue. 
Current Study - 37 immature teratomas - male - 6 (16,2%). 
- female - 31 (83,8%). 
The increased incidence in females was especially evident in the sacrococcygeal plus retroperitoneal locations (in 
addition no immature teratomas of testicular origin were documented, whereas ovarian neoplasms accounted for 24% 
of the total). 
In the study of Harms & Janig, 66% of the immature teratomas occurred in females. 
The ovarian neoplasms presented at a considerably older age than those at other sites (see tabulated data). 
(61) 
Clinical Outcome 
Follow up data was unfortunately available for only 23 (62%) of the cases. With regard to these 23 cases: 
- 2 Tumour related deaths occurred. 
- And an additional 2 patients developed metastatic disease. 
(For details of the above please see tabulated data). 
Thus only 4 (17%) of the 23 patients with follow up data had complicated clinical courses. (An additional single 
patient developed tumour recurrence, 9 months after the original excision). The other 18 patients had uneventful 
courses following complete surgical excision alone. 
Comparison of the clinical outcome of the current study with that ofKooijman [591 
Study No. Of Cases No. Of cases No. Of cases No. Of cases No. Of tumour 
with follow UI! recurring with a develoJ!ing recurring related deaths 
data Y.S.T. metastatic dis. {Excluding 
com~nent. (Excluding those develoJ!ing 
those recurring aY.S.T. 
with a Y.S.T. COMJ!Onent} 
comoonent) 
Kooijman 27 2 (Both 1 2 (Grade II, 2 (- Grade I, 
sacrococcygeal, ( Sacrococcygeal, sacrococcygeal + sacrococcygeal, 
Grade I and Grade II, single Grade IIL recurring with a 
Grade III liver metastasis) ovarian) YST component. 
respectively) - Intracranial 
imm. Teratoma, 
death from raised 
I.C.P.) 
Current Study 23 l (Grade II, 3 l ( - Grade II. 2 ( - Grade II 




metastases. -Grade II 
- Grade III, sacrococcygeal 
ovarian, glial recurring with 
nodules in Y.S.T. 
peritoneal component) 
vessels. 
- Grade III. 
neck, metastases 
to local cervical 
lymph nodes) 
Combination of 50 3 (6%) 4 (8%) 3 (6%) 4 (8%) 
present study and 
that of Kooiiman 
(62) 
On combining the results of the current study with those of Kooijman. it becomes apparent. with regard to immature 
teratomas of childhood, that: 
1. The outcome is usually favourable (mortality rate less than 10%). 
2. Metastatic disease is uncommon (less than 10% of cases). 
3. Recurrence ""ith a Y.S.T. component is rare (6% of cases) - in these 2 studies occurring only in sacrococcygeal 
tumours, and with all tumour grades. 
4. Recurrence of tumour following complete surgical excision is rare (6% of cases). 
Relationship between tumour grade plus other histological factors, and outcome. 
As the majority of childhood immature teratomas appear to have an uncomplicated clinical course following complete 
surgical excision, it is difficult to establish definite prognostic factors. 
I. Tumour grade - In the current study complications were confined to grade II and III tumours. (Kooijman does 
however document a grade I sacrococcygeal tumour which recurred with a Y.S.T. component). 
2. Mitotic count. microscopic necrosis. anaplasia, vascular invasion - there was no correlation between these 
variables and clinical outcome (anaplasia. and vascular invasion. could in fact not be identified in any of the cases 
examined) - see tabulated data below. 
Relationship (or lack thereof) between immature teratomas with a complicated clinical course (in the current study) 
and mitotic rate plus microscopic necrosis : 
Site Complication Mitotic count/IOHPF Microscopic necrosis 
Sacrococcygeal Recurrence of grd II 1/lOHPF Absent 
tumour with a Y. S. T. 
component. 
Ovary Grd II tumour with 18/lOHPF Present (extensive) 
extensive metastatic 
peritoneal deposits, 
resulting in death of 
patient. 
Grd III tumour with glial <1/lOHPF Present (scanty) 
nodules demonstrated in 
peritoneal blood vessels. 
Neck Grd III tumour with <lllOHPF Absent 
metastases to adjacent 
cervical lymph nodes. 
Pharynx Grd II tumour. recurrence 0/lOHPF Absent 
9 months after original 
excision. 
3. Presence of non neural immature tissue (rhabdomyoblastic, renal, and mesenchJmal) - These had no adverse effect 
on the clinical outcome. 
(63) 
Relationship between tumour grade and other histological variables. 
1. Mitotic rate - In the current study the mitotic rate correlated with the nature of the immature neural tissue present 
(low with neuroglial and high °\\'1th neuroepithelial tubules) rather than the tumour grade. Thus addition of 
mitotic rate to the grading system is unlikely to be of benefit. 
2. Microscopic necrosis - The presence of microscopic necrosis did correlate °\\'1th tumour grade - of the 10 cases with 
microscopic necrosis only one (with scanty necrosis) occurred in a Grade I tumour (the other 9 cases all being 
associated with Grade II/III tumours). However, as this variable when evaluated alone, did not correlate with 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Footnote to table summarising data on yolk sac tumours 
1. Sacrococcygeal Y.S.T. 
- In two of the cases, the primary tumours were a mature and an immature teratoma respectively, with only 
the recurrence/metastatic deposit showing a Y.S.T. component. 
- The histological data, from one of the cases, refers to metastatic tumour (the original primary 
sacrococcygeal tumour being a mature teratoma - see above). 
- The mean maximum tumour diam. given, is from data on only 3 cases (the majority of tumours could 
either not be fully excised or were removed piecemeal). 
2. Testicular Y.S.T. 
- The mean max. tumour diam. is from data on 9 cases only. 
3. Retroperitoneal Y.S.T. 
- The mean max. tumour diam. is from data on one case only. 
4. Mediastinal Y.S.T. 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SUMMARY OF FACTORS CLINICAL AND PATHOLOGICAL, INFLUENCING THE CLINICAL OUTCOME OF 
MALIGNANT GERM CELL TUMOURS OF CHILDHOOD. 
I) Clinical 
A) Site 
The significance of anatomical location is exemplified by the outcome of those with testicular Y. S. T. ( 100% 
alive and free of disease), as opposed to the sacrococcygeal-retroperitoneal group (57% mortality rate, with 
overall 86% either dying or developing disseminated disease) plus the ovarian group (40% mortality rate). 
The cause of this discrepancy in prognosis between tumours which are histologically identical is unclear. 
Tumour longevity prior to diagnosis may be of significance. The testicular lesions occurring in a 
superficialf'exposed" location will be diagnosed at an earlier stage in their development (see tabulated data 
on size of neoplasms), and theoretically have had less time to form cell clones with metastasizing capability, 
than those tumours in cryptic locations (ovarian, sacrococcygeal, retroperitoneal). 
B) Age 
[This factor is of most importance as a potential predictor of biological behaviour ofsacrococcygeal tumours 
- with only 2 (15%)/36 neoplasms present at birth showing malignant histology, as opposed to 13 (72%) of 
18 diagnosed later in infancy]. 
As a group the testicular Y. S. T. occurred at a significantly younger age than those in the poor prognosis 
locations (ovary, retroperitoneum, sacrococcygeal region) - see comment on tumour longevity above. 
In addition, \\ith regard to testicular Y.S.T., infants less than 24 months of age are generally held to have a 
better prognosis £2. 112. !!3] (It should however be noted, that in the childhood series of Hawkins et al DS], 
advanced age beyond 24 months did not adversely affect the prognosis. In the current study only one child 
was older than 24 months, precluding personal comment). 
C) Therapy administered 
Modem day multi drug chemotherapy has dramatically altered the prognosis for malignant g.c.t. All 8 of the 
patients (with available data) diagnosed prior to 1981 as having Y.S.T. of the ovary, retroperitoneum or 
sacrococcygeal region died. By contrast, in only 1 of 10 patients diagnosed since 1981 was death 
documented. 
II) Pathological 
A) Tumour size 
As a group the testicular Y. S. T. were of a significantly smaller size than those in the poor prognosis 
locations - see comment above on tumour longevity. 
B) Histological malignant G.C.T. type 
1. Embryonal carcinoma - With regard to the malignant testicular g.c.t., the only death, as well as 
the only 2 cases of visceral metastases, occurred amongst the 3 patients with a definite or 
possible embryonal carcinoma component. 
2. Germinomas - All 5 patients with ovarian dysgerminomas were alive at documentation (4 free 
of disease) - consistent with the excellent prognosis of this radiosensitive neoplasm. 
(66) 
C) Y.S.T. Histological subtype 
Review of the Y.S.Ts with clinical follow up revealed 7 (30%) deaths amongst 23 patients with histologically 
pure tumours, and 2 (18%) deaths amongst 11 with mixed (Y.S.T. + mature/immature teratoma). These 
findings are of doubtful significance. D5] Hawkins et al in their review of 89 childhood Y.S.T. found no 
statistically significant difference in behaviour between pure and mixed tumours. 
D) Predominant Y.S.T. Histological pattern 
Review of the data for the 37 primary yolk sac tumours shows: 
- No predominant histological pattern - 21 cases. 
- Reticular pattern predominant - 11 cases. 
- Papillary pattern predominant - 2 cases. 
- Trabecular pattern predominant - l case. 
- Mixed trabecular - polyvesicular - vitelline pattern - l case. 
- Solid pattern predominant - 1 case. 
No correlation could be demonstrated between predominant histological pattern and outcome. 
E) Mitotic rate plus microscopic necrosis 
There was no statistically significant difference in mitotic rate, or incidence of microscopic necrosis, 
between the excellent prognosis group (testicular) and the poor prognosis group (sacrococcygeal - ovarian -
retroperitoneal). 
F) Vascular invasion+ anaplasia. 
1. With regard to non testicular malignant g.c.t. these variables were not shown to be of prognostic 
importance (see data below). 
Anaplasia present 
Anaplasia absent 
Vascular invasion present 
Vascular invasion absent 
Percentage patients dying or developing 





2. Two of the 3 cases with a possible/definite testicular embryonal carcinoma component showed 
both anaplasia and vascular invasion. Visceral metastases developed in both these patients. 
SUMMARY OF DATA ON MATu'RE TERATOMAS 
Location Total No. Of Mean age. Sex Mean Mas No. of cases 
cases(%of (Range) F M rumour diam recurring as 
total no. of (mm). (Range) malignant 
mature tumours oc as 
teratomas) immature 
t~atomas 
Ovarian 30 66months 30 0 86 0 
(35,3%) (3 wedcs to 12 (22 to 130)' 
years) 
Sacrococcygeal 27 3~, weeks 18 7 75 l - Recurrence 
(31,7%) (Birth to 30 (30 to 130) with YST 
weeks) componenl 
Media~1inal 8 41,S months s 3 9S 0 
(9,4%) (Birth to 13 (40 to 200) 
years) 
Neck 6 All present at 4 2 77 0 
(7%) birth (40to 100) 
1 Testicular 4 45,5 months 0 4 30 0 
(4,7%) (l 4 months to (20to40) 
84 months) 
Retroperitoneal 3 5,3 months 2 l 102,5 0 
(3,5%) (Birth to 8 (100 to 105) 
months) 
Par.1v~ral 3 (Birth to several 1 1 (25 to 60) 0 
(3,5%) months) 
Renal 2 ( 4 months and 2 0 (110 to 120) 0 
(203%) 13montbs) 
Face (cheek) l 4years l 0 
(l,2%) 
I Orbit J Birth J 0 Pi<l!.:em~a.J 0 
l (1.2%) rese..'lion 
Total 85 64 18 l 
(78,1%) (21%) (l,2%) 
Footnou: In some instances data was not available for all tJ1e cases (see relevant specific organ systems). 
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